For how we live.
A Danish stepped-wedge trial gave endoscopists automated feedback on their technique after every procedure. Adenoma detection rose from 43.4% to 48.6% — a different tool from real-time polyp AI.
Dense tissue raises breast-cancer risk and hides cancers on a mammogram. US facilities must now tell patients — but the evidence on what to do next is a real trade-off: more cancers found, more false alarms.
US guidance recommends mammography from 40. A Canadian review of the same randomised evidence put the benefit at 0.27 fewer breast cancer deaths per 1,000 women aged 40-49 over ten years.
That is the 23-year result from the largest randomised trial. A 2026 Cochrane review of 789,086 men rates the mortality benefit moderate-certainty and the harms largely unmeasured.
Integrated risk scores combine polygenic data with conventional risk factors. A readiness review lists what would have to exist first — and separately, 36% of older Australians had no skin check at all last year.
The EAGLE trial ran colonoscopy AI off-site over a network and aimed it at the lesions that matter. It reports a threefold gain in serrated lesions — in a field whose main US guideline recommends nothing.